-+ 0.00%
-+ 0.00%
-+ 0.00%

BNP Paribas Reiterates Outperform on Versigent, Lowers Price Target to $54

Benzinga·11/05/2026 17:22:21
Listen to the news
BNP Paribas analyst James Picariello reiterates Versigent (NYSE:VGNT) with a Outperform and lowers the price target from $55 to $54.